Data from animal models is now available to initiate assessment of human safety and feasibility of wide-angle three-dimensional intracardiac echocardiography (3D ICE) to guide point-of-care implantation of percutaneous left ventricular assist devices in critical care settings. Assessment of these combined new technologies could be best achieved within a surgical institution with pre-existing expertise in separate utilization of ICE and Impella.
YastrebovKBrunelLPatersonHS, et al.Implantation of Impella CP left ventricular assist device under the guidance of three-dimensional intracardiac echocardiography. Sci Rep. 2020;10:17485. DOI: 10.1038/s41598-020-74220-8
2.
RuanQYangKWangWJiangLSongJ. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846-848. DOI: 10.1007/s00134-020-05991-x.
3.
Advanced pulmonary and cardiac support of COVID-19 patients, emerging recommendations from ASAIO. Circulation: Heart Fail2020;13:e007175. DOI: 10.1161/CIRCHEARTFAILURE.120.007175.
4.
VallabhajosyulaSO’HoroJCAntharamP, et al.Venoarterial extracorporeal membrane oxygenation with concomitant Impella versus venoarterial extracorporeal membrane oxygenation for cardiogenic shock. Am Soc Artif Intern Organs J. 2020;66:497-503. DOI: 10.1097/MAT.0000000000001039.
5.
BarbaroRPMacLarenGBoonstraPS, et al.Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the extracorporeal life support organization registry. Lancet. 2020;396:1071-1078. DOI: 10.1016/S0140-6736(20)32008-0
KirkpatrickJNMitchellCTaubCKortSHungJSwaminathanM. ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak: endorsed by the American college of cardiology. J Am Soc Echocardiogr. 2020;33:648-653. DOI: 10.1016/j.echo.2020.04.001
